#USA #New York #NASDAQ #uniQure #QURE

Investor Class Action Alert: Take Note of the Upcoming Deadline

Faruqi & Faruqi, LLP, a prominent national securities law firm, has issued a significant warning for investors in uniQure N.V. (NASDAQ: QURE). The firm is currently investigating potential claims against the company regarding its compliance with federal securities laws. Investors are reminded that the deadline to apply as a lead plaintiff in a federal securities class action is April 13, 2026.

Background of the Case

The investigation stems from allegations that uniQure may have misrepresented crucial information to its stakeholders. The firm's complaints highlight serious concerns regarding the company's pivotal study and its interaction with the FDA. Specifically, the firm claims that uniQure failed to disclose that key designs of the pivotal study had not received full approval from the FDA, which is critical for the submission of Biologics License Applications (BLAs).

The firm’s investigation gained momentum after November 3, 2025, when uniQure disclosed that the FDA's stance on data adequacy for the BLA submission had changed. This led to an immediate and severe decline in the company’s stock price, plummeting nearly 50% in one day, illustrating the grave impact of the news on investors.

Who Should Take Action?

Investors who suffered losses exceeding $50,000 in uniQure’s stock between September 24, 2025, and October 31, 2025, are particularly urged to reach out to the firm. Senior Partner Josh Wilson is encouraging these individuals to discuss their options directly, reinforcing that there is no obligation to participate in the lawsuit unless they choose to do so. Interested investors have the right to move the Court to act as lead plaintiff, which entails directing and overseeing the lawsuit on the class's behalf.

The process for becoming a lead plaintiff is straightforward, and any member of the putative class can initiate the motion for this role through their counsel. However, those who prefer not to take on this responsibility may still participate as absent class members, retaining their eligibility to benefit from any recovery resulting from the action.

Faruqi & Faruqi is also proactive in soliciting information from anyone with insights regarding uniQure’s practices—this includes whistleblowers, former employees, and shareholders. Such contributions can be critical in building a more comprehensive case against the company.

The Importance of Timeliness

Investors are reminded of the urgency of this matter. The April 13, 2026, deadline looms, and prompt action can make a significant difference in the outcome of potential claims. Interested parties are encouraged to contact Faruqi & Faruqi to learn more about their rights and the evolving situation surrounding uniQure.

For comprehensive details regarding this class action lawsuit, personnel can visit the Faruqi & Faruqi website or reach out directly to partner Josh Wilson at the provided phone numbers.

This legal situation serves as a stark reminder of the importance of transparency and accountability within corporate governance and the necessity for investors to remain vigilant about their investments. Faruqi & Faruqi continues to uphold its commitment to defending investor rights and facilitating recovery for those wronged by corporate misconduct.

Source: Faruqi & Faruqi, LLP